Earnings call CAREL Industries reported FY 2025 revenue of EUR 629 million, up 8.7% YoY (10.6% organic), with Q4 organic growth accelerating to 16.9%. Adjusted EBITDA margin reached 20%, and net ...
Claude Code loop skill runs prompts on a schedule but auto-expires after 3 days, limiting long-term automation for ongoing ...
Outcomes from EVOLUTION 2 study include 68% time in range with no boluses Diverse multicenter feasibility study highlights the promise of future Omnipod innovation to address unmet needs, improve ...
Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results